As of November 30, 2023 T3 Labs is Part of Veranex. Click Here to learn more.
GCMI Design & Development has moved to gcmiatl.org
Aprons of Shield set out to design a device that achieves full-body shielding from radiation for clinicians while still giving them the ability to use their hands without being weighed down by aprons or increasing exposure.
As the year comes to a close and many of us look forward to a holiday respite, I find myself full of enthusiasm having recently returned from Israel advancing our accelerator program with Rambam Health Center and participating in the mHEALTH Israel Women’s Meetup at Google for Startups Campus in Tel Aviv. We live in…
Georgia Tech Biomedical Engineering students Robert Bridenhagen, Gabriel Cruz, and Annika Clawson teamed up with Computer Engineering student Matthew Aspinwall and Electrical Engineering student Matthew Zilvetti to form the interdisciplinary team S.A.V.A.G.E.
Leading Lap has redesigned the trocar’s tip to prevent puncturing or injuring organs upon insertion. Georgia Tech biomedical engineering students Hailey Avis, Cameron Bennett, Will Kamnick and Katherine Strickland make up this team for the Fall 2019 Capstone Design Expo.
Thanks to GCMI’s Capstone Day, the team was able to use their device in a highly clinical, practical situation. “Being able to test the device in a cadaveric setting thanks to GCMI was the best opportunity we could have been afforded at this stage,” Lando said.
Good laboratory practice (GLP) studies are an essential component to medical product development and regulatory submissions. They are highly rigorous, are conducted in compliance with a legally bound code of federal regulations (21 CFR Part 58) and should be conducted by qualified scientists and staff of an accredited contract research organization (CRO). They are also…
Finding a trustworthy CRO for preclinical studies is a top priority for medical product innovators. It is always more cost-effective for companies to get it right the first time when selecting data sets, study endpoints and a preclinical partner. In other words, the most expensive study is the one you have to repeat.
GCMI’s foremost goal as an affiliate of the Georgia Institute of Technology is to partner with Georgia Tech faculty and engineers in the innovation process of new medical products. One successful example of this partnership has been our work with Dr. Scott Hollister. With GCMI’s help, Children’s Healthcare of Atlanta surgeons used Dr. Hollister’s process…
Ben Glenn, Dev Kurkidar, Shar Matin, Paul Snyder and Tiffany Wilson shared their insights into “De-Risking Medtech Innovation by Investing in the Process Before the Product,” with more than 100 early and emerging-growth medical technology executives seeking to bring their innovations to market.
“Is Getting New Treatments to Patients Harder Than Landing on Mars?” Georgia Tech Research Horizons Senior Science Writer, Ben Brumfield, recently enlisted GCMI CEO, Tiffany Wilson, to help answer the question. According to the article, only 15% of new therapies make it to patients, and getting a new treatment to market can require $1 billion in pharmaceutical company investment, “more than the entire budget for the latest NASA Mars mission.”